MedTrace Logo

HKT-500-US12 In Adult Patients With OA Knee Pain

NCT00647231 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-06-04

No results posted yet for this study

Summary

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

HKT-500 Topical Patch

Treatment with Ketoprofen Topical Patch

OTHER

Placebo Patch

Treatment with placebo patch

Sponsors & Collaborators

  • Hisamitsu Pharmaceutical Co., Inc.

    lead INDUSTRY

Principal Investigators

  • Kenichi Furuta · Hisamitsu

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00647231 on ClinicalTrials.gov